{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:49:39Z","timestamp":1775742579846,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"DOI":"10.7759\/cureus.106713","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:48:27Z","timestamp":1775738907000},"source":"Crossref","is-referenced-by-count":0,"title":["Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety"],"prefix":"10.7759","author":[{"given":"Juana","family":"Montero Bernaldez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(84)90008-2","article-title":"The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results","volume":"6","author":"Burger HG","year":"1984","unstructured":"Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas. 1984, 6:351-358. 10.1016\/0378-5122(84)90008-2","journal-title":"Maturitas"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/13697130600643437","article-title":"Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports","volume":"9","author":"Gambrell RD Jr","year":"2006","unstructured":"Gambrell RD Jr, Natrajan PK. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports. Climacteric. 2006, 9:224-233. 10.1080\/13697130600643437","journal-title":"Climacteric"},{"key":"ref3","article-title":"A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density","volume":"78","author":"Garnett T","year":"1991","unstructured":"Garnett T, Studd J, Watson N, Savvas M. A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density. Obstet Gynecol. 1991, 78:1002-1007.","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1981.tb01008.x","article-title":"Hormonal profiles in postmenopausal women after therapy with subcutaneous implants","volume":"88","author":"Thom MH","year":"1981","unstructured":"Thom MH, Collins WP, Studd JW. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. Br J Obstet Gynaecol. 1981, 88:426-433. 10.1111\/j.1471-0528.1981.tb01008.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000119983.48235.d3","article-title":"Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy","volume":"11","author":"Dimitrakakis C","year":"2004","unstructured":"Dimitrakakis C, Jones RA, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause. 2004, 11:531-535. 10.1097\/01.gme.0000119983.48235.d3","journal-title":"Menopause"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2313307","article-title":"Sexual dysfunction in women","volume":"391","author":"Davis SR","year":"2024","unstructured":"Davis SR. Sexual dysfunction in women. N Engl J Med. 2024, 391:736-745. 10.1056\/NEJMcp2313307","journal-title":"N Engl J Med"},{"key":"ref7","unstructured":"Advisory Committee for Reproductive Health Drugs; notice of meeting. (2004). Accessed. June\u202f11,\u202f2025: https:\/\/www.federalregister.gov\/documents\/2004\/10\/28\/04-24068\/advisory-committee-for-reproductive-health-drugs-notice...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2010.12.001","article-title":"Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)","volume":"68","author":"Glaser R","year":"2011","unstructured":"Glaser R, York AE, Dimitrakakis C. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas. 2011, 68:355-361. 10.1016\/j.maturitas.2010.12.001","journal-title":"Maturitas"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1941.02820520003002","article-title":"Androgen therapy in gynecology","volume":"117","author":"Geist SH","year":"1941","unstructured":"Geist SH, Salmon UJ. Androgen therapy in gynecology. JAMA. 1941, 117:2207-2215. 10.1001\/jama.1941.02820520003002","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)40839-2","article-title":"The treatment of abnormal uterine bleeding with androgens: therapeutic evaluation of testosterone propionate, methyl testosterone, ethinyl testosterone and androgen implantation","volume":"41","author":"Salmon UJ","year":"1941","unstructured":"Salmon UJ, Geist SH, Gaines JA, Walter RI. The treatment of abnormal uterine bleeding with androgens: therapeutic evaluation of testosterone propionate, methyl testosterone, ethinyl testosterone and androgen implantation. Am J Obstet Gynecol. 1941, 41:991-1009. 10.1016\/S0002-9378(16)40839-2","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-7207(00)00425-1","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women","volume":"171","author":"Luu-The V","year":"2001","unstructured":"Luu-The V, Dufort I, Pelletier G, Labrie F. Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol. 2001, 171:77-82. 10.1016\/s0303-7207(00)00425-1","journal-title":"Mol Cell Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/13697130902973227","article-title":"The role of testosterone in women","volume":"12","author":"Panay N","year":"2009","unstructured":"Panay N, Fenton A. The role of testosterone in women. Climacteric. 2009, 12:185-187. 10.1080\/13697130902973227","journal-title":"Climacteric"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)02969-2","article-title":"Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment","volume":"77","author":"Bachmann G","year":"2002","unstructured":"Bachmann G, Bancroft J, Braunstein G, et al.. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002, 77:660-665. 10.1016\/s0015-0282(02)02969-2","journal-title":"Fertil Steril"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.10.4306","article-title":"Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women","volume":"82","author":"Labrie F","year":"1997","unstructured":"Labrie F, Diamond P, Cusan L, Gomez JL, B\u00e9langer A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 1997, 82:3498-3505. 10.1210\/jcem.82.10.4306","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(96)03819-1","article-title":"A and B forms of the androgen receptor are expressed in a variety of human tissues","volume":"120","author":"Wilson CM","year":"1996","unstructured":"Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol. 1996, 120:51-57. 10.1016\/0303-7207(96)03819-1","journal-title":"Mol Cell Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1260017","article-title":"Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor","volume":"126","author":"Takeda H","year":"1990","unstructured":"Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C. Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. J Endocrinol. 1990, 126:17-25. 10.1677\/joe.0.1260017","journal-title":"J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2217\/whe.12.11","article-title":"The safety of postmenopausal testosterone therapy","volume":"8","author":"Maclaran K","year":"2012","unstructured":"Maclaran K, Panay N. The safety of postmenopausal testosterone therapy. Womens Health (Lond). 2012, 8:263-275. 10.2217\/whe.12.11","journal-title":"Womens Health (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004509.pub2","article-title":"Testosterone for peri and postmenopausal women","author":"Somboonporn W","year":"2005","unstructured":"Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri and postmenopausal women. Cochrane Database Syst Rev. 2005, CD004509. 10.1002\/14651858.CD004509.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(12)70125-1","article-title":"Subgroups of patients treated with an aromatase inhibitor (anastrozole) delivered subcutaneously in combination with testosterone","volume":"71","author":"Glaser R","year":"2012","unstructured":"Glaser R, Dimitrakakis C. Subgroups of patients treated with an aromatase inhibitor (anastrozole) delivered subcutaneously in combination with testosterone. Maturitas. 2012, 71:S31. 10.1016\/S0378-5122(12)70125-1","journal-title":"Maturitas"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.4.7714119","article-title":"Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women","volume":"80","author":"Zumoff B","year":"1995","unstructured":"Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995, 80:1429-1430. 10.1210\/jcem.80.4.7714119","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison SL","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005, 90:3847-3853. 10.1210\/jc.2005-0212","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901176","article-title":"Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: part B: reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction","volume":"16","author":"Guay A","year":"2004","unstructured":"Guay A, Jacobson J, Munarriz R, et al.. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: part B: reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res. 2004, 16:121-129. 10.1038\/sj.ijir.3901176","journal-title":"Int J Impot Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger HG","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002, 77:S3-S5. 10.1016\/s0015-0282(02)02985-0","journal-title":"Fertil Steril"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.8.4160","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie F","year":"1997","unstructured":"Labrie F, B\u00e9langer A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997, 82:2396-2402. 10.1210\/jcem.82.8.4160","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0173(01)00133-3","article-title":"Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging","volume":"37","author":"Ferrari E","year":"2001","unstructured":"Ferrari E, Casarotti D, Muzzoni B, et al.. Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging. Brain Res Brain Res Rev. 2001, 37:294-300. 10.1016\/s0165-0173(01)00133-3","journal-title":"Brain Res Brain Res Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.11.004","article-title":"Testosterone implants in women: pharmacological dosing for a physiologic effect","volume":"74","author":"Glaser R","year":"2013","unstructured":"Glaser R, Kalantaridou S, Dimitrakakis C. Testosterone implants in women: pharmacological dosing for a physiologic effect. Maturitas. 2013, 74:179-184. 10.1016\/j.maturitas.2012.11.004","journal-title":"Maturitas"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00721.x","article-title":"The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action","volume":"5","author":"Carruthers M","year":"2008","unstructured":"Carruthers M. The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action. J Sex Med. 2008, 5:998-1012. 10.1111\/j.1743-6109.2007.00721.x","journal-title":"J Sex Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/2042018810379588","article-title":"Testosterone therapy for reduced libido in women","volume":"1","author":"Basson R","year":"2010","unstructured":"Basson R. Testosterone therapy for reduced libido in women. Ther Adv Endocrinol Metab. 2010, 1:155-164. 10.1177\/2042018810379588","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.01121.x","article-title":"Testosterone therapy in women with gynecological and sexual disorders: a triumph of clinical endocrinology from 1938 to 2008","volume":"6","author":"Traish AM","year":"2009","unstructured":"Traish AM, Feeley RJ, Guay AT. Testosterone therapy in women with gynecological and sexual disorders: a triumph of clinical endocrinology from 1938 to 2008. J Sex Med. 2009, 6:334-351. 10.1111\/j.1743-6109.2008.01121.x","journal-title":"J Sex Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(00)00930-3","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein L","year":"2000","unstructured":"Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000, 96:351-358. 10.1016\/s0029-7844(00)00930-3","journal-title":"Obstet Gynecol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12081194","article-title":"A personal prospective on testosterone therapy in women-what we know in 2022","volume":"12","author":"Donovitz GS","year":"2022","unstructured":"Donovitz GS. A personal prospective on testosterone therapy in women-what we know in 2022. J Pers Med. 2022, 12:1194. 10.3390\/jpm12081194","journal-title":"J Pers Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Laumann EO","year":"1999","unstructured":"Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999, 281:537-544. 10.1001\/jama.281.6.537","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000060256.03945.20","article-title":"Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women","volume":"10","author":"Goldstat R","year":"2003","unstructured":"Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 2003, 10:390-398. 10.1097\/01.GME.0000060256.03945.20","journal-title":"Menopause"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-8-200804150-00001","article-title":"Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial","volume":"148","author":"Davis S","year":"2008","unstructured":"Davis S, Papalia MA, Norman RJ, et al.. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med. 2008, 148:569-577. 10.7326\/0003-4819-148-8-200804150-00001","journal-title":"Ann Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman Y","year":"2014","unstructured":"Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014, 20:76-105. 10.1093\/humupd\/dmt038","journal-title":"Hum Reprod Update"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/0531-5565(94)90021-3","article-title":"Sex hormones and psychological functioning in postmenopausal women","volume":"29","author":"Sherwin BB","year":"1994","unstructured":"Sherwin BB. Sex hormones and psychological functioning in postmenopausal women. Exp Gerontol. 1994, 29:423-430. 10.1016\/0531-5565(94)90021-3","journal-title":"Exp Gerontol"},{"key":"ref37","article-title":"Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses","volume":"43","author":"Sarrel P","year":"1998","unstructured":"Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med. 1998, 43:847-856.","journal-title":"J Reprod Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2013.08.002","article-title":"Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study","volume":"76","author":"Glaser RL","year":"2013","unstructured":"Glaser RL, Dimitrakakis C. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. Maturitas. 2013, 76:342-349. 10.1016\/j.maturitas.2013.08.002","journal-title":"Maturitas"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01772.x","article-title":"Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men","volume":"58","author":"Diver MJ","year":"2003","unstructured":"Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf). 2003, 58:710-717. 10.1046\/j.1365-2265.2003.01772.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021878","article-title":"Seasonal variation of testosterone and waist to hip ratio in men: the Troms\u00f8 study","volume":"88","author":"Svartberg J","year":"2003","unstructured":"Svartberg J, Jorde R, Sundsfjord J, B\u00f8naa KH, Barrett-Connor E. Seasonal variation of testosterone and waist to hip ratio in men: the Troms\u00f8 study. J Clin Endocrinol Metab. 2003, 88:3099-3104. 10.1210\/jc.2002-021878","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(73)91601-2","article-title":"Fall in plasma-testosterone levels in normal male subjects in response to an oral glucose load","volume":"1","author":"Wall JR","year":"1973","unstructured":"Wall JR, Jarrett RJ, Zimmet PZ, Bailes M, Ramage CM. Fall in plasma-testosterone levels in normal male subjects in response to an oral glucose load. Lancet. 1973, 1:967-968. 10.1016\/s0140-6736(73)91601-2","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-004-1223-1","article-title":"Relationship between stress hormones and testosterone with prolonged endurance exercise","volume":"93","author":"Daly W","year":"2005","unstructured":"Daly W, Seegers CA, Rubin DA, Dobridge JD, Hackney AC. Relationship between stress hormones and testosterone with prolonged endurance exercise. Eur J Appl Physiol. 2005, 93:375-380. 10.1007\/s00421-004-1223-1","journal-title":"Eur J Appl Physiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman HA","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA, et al.. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002, 87:589-598. 10.1210\/jcem.87.2.8201","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139003353.006","article-title":"The behavioral correlates of testosterone","author":"Bancroft J","year":"2012","unstructured":"Bancroft J. The behavioral correlates of testosterone. Testosterone: Action, Deficiency, Substitution. Nieschlag E, Behre HM, Nieschlag S (ed): Cambridge University Press, 2012. 87-122. 10.1017\/CBO9781139003353.006"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.5.8626841","article-title":"Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males","volume":"81","author":"Vermeulen A","year":"1996","unstructured":"Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996, 81:1821-1826. 10.1210\/jcem.81.5.8626841","journal-title":"J Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01653.x","article-title":"Significant ethnic variation in total and free testosterone concentration","volume":"58","author":"Heald AH","year":"2003","unstructured":"Heald AH, Ivison F, Anderson SG, Cruickshank K, Laing I, Gibson JM. Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf). 2003, 58:262-266. 10.1046\/j.1365-2265.2003.01653.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2004.02.005","article-title":"The \"trouble\" with salivary testosterone","volume":"29","author":"Granger DA","year":"2004","unstructured":"Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB. The \"trouble\" with salivary testosterone. Psychoneuroendocrinology. 2004, 29:1229-1240. 10.1016\/j.psyneuen.2004.02.005","journal-title":"Psychoneuroendocrinology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(01)01148-9","article-title":"Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men","volume":"50","author":"Seidman SN","year":"2001","unstructured":"Seidman SN, Araujo AB, Roose SP, McKinlay JB. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry. 2001, 50:371-376. 10.1016\/s0006-3223(01)01148-9","journal-title":"Biol Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2605.2003.00393.x","article-title":"The CAG repeat polymorphism within the androgen receptor gene and maleness","volume":"26","author":"Zitzmann M","year":"2003","unstructured":"Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl. 2003, 26:76-83. 10.1046\/j.1365-2605.2003.00393.x","journal-title":"Int J Androl"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.076","article-title":"Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels","volume":"42","author":"Smets EM","year":"2004","unstructured":"Smets EM, Dijkstra-Lagemaat JE, Blankenstein MA. Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels. Clin Chem Lab Med. 2004, 42:435-439. 10.1515\/CCLM.2004.076","journal-title":"Clin Chem Lab Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner W","year":"2010","unstructured":"Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab. 2010, 95:4542-4548. 10.1210\/jc.2010-1314","journal-title":"J Clin Endocrinol Metab"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.01.006","article-title":"Testosterone in women: measurement and therapeutic use","volume":"39","author":"Kathryn Korkidakis A","year":"2017","unstructured":"Kathryn Korkidakis A, Reid RL. Testosterone in women: measurement and therapeutic use. J Obstet Gynaecol Can. 2017, 39:124-130. 10.1016\/j.jogc.2017.01.006","journal-title":"J Obstet Gynaecol Can"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1250","article-title":"Immunoassays for testosterone in women: better than a guess?","volume":"49","author":"Herold DA","year":"2003","unstructured":"Herold DA, Fitzgerald RL. Immunoassays for testosterone in women: better than a guess?. Clin Chem. 2003, 49:1250-1251. 10.1373\/49.8.1250","journal-title":"Clin Chem"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(97)00464-0","article-title":"Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability","volume":"69","author":"Boots LR","year":"1998","unstructured":"Boots LR, Potter S, Potter D, Azziz R. Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril. 1998, 69:286-292. 10.1016\/s0015-0282(97)00464-0","journal-title":"Fertil Steril"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.8.6740","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition","volume":"85","author":"Burger HG","year":"2000","unstructured":"Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000, 85:2832-2838. 10.1210\/jcem.85.8.6740","journal-title":"J Clin Endocrinol Metab"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner W","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007, 92:405-413. 10.1210\/jc.2006-1864","journal-title":"J Clin Endocrinol Metab"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa126","article-title":"Response to letter to the editor: \"Global Consensus Position Statement on the use of testosterone therapy for women\"","volume":"105","author":"Davis SR","year":"2020","unstructured":"Davis SR, Baber R, Panay N, Pinkerton J. Response to letter to the editor: \"Global Consensus Position Statement on the use of testosterone therapy for women\". J Clin Endocrinol Metab. 2020, 105:dgaa126. 10.1210\/clinem\/dgaa126","journal-title":"J Clin Endocrinol Metab"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/13685530701342686","article-title":"Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry","volume":"10","author":"Morales A","year":"2007","unstructured":"Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A, Tremblay R. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. The Aging Male. 2007, 10:57-65. 10.1080\/13685530701342686","journal-title":"The Aging Male"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(03)00204-8","article-title":"Androgens in women","volume":"85","author":"Davison SL","year":"2003","unstructured":"Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol. 2003, 85:363-366. 10.1016\/s0960-0760(03)00204-8","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3109\/13685538.2015.1004047","article-title":"Testosterone threshold-does one size fit all?","volume":"18","author":"Maganty A","year":"2015","unstructured":"Maganty A, Shoag JE, Ramasamy R. Testosterone threshold-does one size fit all?. Aging Male. 2015, 18:1-4. 10.3109\/13685538.2015.1004047","journal-title":"Aging Male"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.10.007","article-title":"Risks of testosterone for postmenopausal women","volume":"50","author":"Pinkerton JV","year":"2021","unstructured":"Pinkerton JV, Blackman I, Conner EA, Kaunitz AM. Risks of testosterone for postmenopausal women. Endocrinol Metab Clin North Am. 2021, 50:139-150. 10.1016\/j.ecl.2020.10.007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002190","article-title":"Testosterone use for hypoactive sexual desire disorder in postmenopausal women","volume":"30","author":"Parish SJ","year":"2023","unstructured":"Parish SJ, Kling JM. Testosterone use for hypoactive sexual desire disorder in postmenopausal women. Menopause. 2023, 30:781-783. 10.1097\/GME.0000000000002190","journal-title":"Menopause"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003324","article-title":"Female sexual dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213","volume":"134","author":"Lindau ST","year":"2019","unstructured":"Lindau ST, Abramsohn E. Female sexual dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019, 134:e1-e18. 10.1097\/AOG.0000000000003324","journal-title":"Obstet Gynecol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1953.63690120004013","article-title":"Effects of intensive sex steroid hormone therapy in advanced breast cancer","volume":"152","author":"Kennedy BJ","year":"1953","unstructured":"Kennedy BJ, Nathanson, IT. Effects of intensive sex steroid hormone therapy in advanced breast cancer. J Am Med Assoc. 1953, 152:1135-1141. 10.1001\/jama.1953.63690120004013","journal-title":"J Am Med Assoc"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(45)90233-X","article-title":"Androgenic therapy in malignant disease of the female genitalia: preliminary report","volume":"49","author":"Abel S","year":"1945","unstructured":"Abel S. Androgenic therapy in malignant disease of the female genitalia: preliminary report. Am J Obstet Gynecol. 1945, 49:327-342. 10.1016\/0002-9378(45)90233-X","journal-title":"Am J Obstet Gynecol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"165","author":"Braunstein GD","year":"2005","unstructured":"Braunstein GD, Sundwall DA, Katz M, et al.. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med. 2005, 165:1582-1589. 10.1001\/archinte.165.14.1582","journal-title":"Arch Intern Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial","volume":"105","author":"Buster JE","year":"2005","unstructured":"Buster JE, Kingsberg SA, Aguirre O, et al.. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005, 105:944-952. 10.1097\/01.AOG.0000158103.27672.0d","journal-title":"Obstet Gynecol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon J","year":"2005","unstructured":"Simon J, Braunstein G, Nachtigall L, et al.. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005, 90:5226-5233. 10.1210\/jc.2004-1747","journal-title":"J Clin Endocrinol Metab"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4133.479","article-title":"Subcutaneous implantation of female and male hormone in tablet form in women","volume":"1","author":"Loeser AA","year":"1940","unstructured":"Loeser AA. Subcutaneous implantation of female and male hormone in tablet form in women. Br Med J. 1940, 1:479-482. 10.1136\/bmj.1.4133.479","journal-title":"Br Med J"},{"key":"ref70","unstructured":"Testosterone insufficiency and treatment in women. international expert consensus. (2019). Accessed: May 15, 2025: https:\/\/medicinaysaludpublica.com\/noticias\/general\/testosterone-insufficiency-and-treatment-in-women-international-ex...."},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam RM","year":"2019","unstructured":"Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019, 7:754-766. 10.1016\/S2213-8587(19)30189-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10655.x","article-title":"Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study","volume":"166","author":"Glaser RL","year":"2012","unstructured":"Glaser RL, Dimitrakakis C, Messenger AG. Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study. Br J Dermatol. 2012, 166:274-278. 10.1111\/j.1365-2133.2011.10655.x","journal-title":"Br J Dermatol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.006","article-title":"Testosterone pellet implants and migraine headaches: a pilot study","volume":"71","author":"Glaser R","year":"2012","unstructured":"Glaser R, Dimitrakakis C, Trimble N, Martin V. Testosterone pellet implants and migraine headaches: a pilot study. Maturitas. 2012, 71:385-388. 10.1016\/j.maturitas.2012.01.006","journal-title":"Maturitas"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1677","article-title":"Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss","volume":"90","author":"Choi HH","year":"2005","unstructured":"Choi HH, Gray PB, Storer TW, et al.. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. J Clin Endocrinol Metab. 2005, 90:1531-1541. 10.1210\/jc.2004-1677","journal-title":"J Clin Endocrinol Metab"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-200106000-00022","article-title":"Androgens in postmenopausal women: production, possible role, and replacement options","volume":"56","author":"Lobo RA","year":"2001","unstructured":"Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv. 2001, 56:361-376. 10.1097\/00006254-200106000-00022","journal-title":"Obstet Gynecol Surv"},{"key":"ref76","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1975.03260240079042","article-title":"Hormone treatment of breast cancer","volume":"234","author":"Segaloff A","year":"1975","unstructured":"Segaloff A. Hormone treatment of breast cancer. JAMA. 1975, 234:1175-1177.","journal-title":"JAMA"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707302","article-title":"Testosterone for low libido in postmenopausal women not taking estrogen","volume":"359","author":"Davis SR","year":"2008","unstructured":"Davis SR, Moreau M, Kroll R, et al.. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008, 359:2005-2017. 10.1056\/NEJMoa0707302","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.01.118","article-title":"Safety of testosterone treatment in postmenopausal women","volume":"88","author":"Braunstein GD","year":"2007","unstructured":"Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril. 2007, 88:1-17. 10.1016\/j.fertnstert.2007.01.118","journal-title":"Fertil Steril"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2008.11.001","article-title":"Study of adverse outcomes in women using testosterone therapy","volume":"62","author":"van Staa TP","year":"2009","unstructured":"van Staa TP, Sprafka JM. Study of adverse outcomes in women using testosterone therapy. Maturitas. 2009, 62:76-80. 10.1016\/j.maturitas.2008.11.001","journal-title":"Maturitas"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(12)70169-X","article-title":"Beneficial effects of subcutaneous testosterone therapy on lipid profiles in women","volume":"71","author":"Glaser R","year":"2012","unstructured":"Glaser R, Dimitrakakis C. Beneficial effects of subcutaneous testosterone therapy on lipid profiles in women. Maturitas. 2012, 71:S41. 10.1016\/S0378-5122(12)70169-X","journal-title":"Maturitas"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01962.x","article-title":"Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy","volume":"7","author":"Traish AM","year":"2010","unstructured":"Traish AM, Gooren LJ. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. J Sex Med. 2010, 7:3758-3764. 10.1111\/j.1743-6109.2010.01962.x","journal-title":"J Sex Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2401","article-title":"Transdermal testosterone in female hypoactive sexual desire disorder: a rapid qualitative systematic review using grading of recommendations assessment, development and evaluation","volume":"10","author":"Ganesan K","year":"2018","unstructured":"Ganesan K, Habboush Y, Sultan S. Transdermal testosterone in female hypoactive sexual desire disorder: a rapid qualitative systematic review using grading of recommendations assessment, development and evaluation. Cureus. 2018, 10:e2401. 10.7759\/cureus.2401","journal-title":"Cureus"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2015.12.033","article-title":"Androgens and female sexual function and dysfunction--findings from the Fourth International Consultation of Sexual Medicine","volume":"13","author":"Davis SR","year":"2016","unstructured":"Davis SR, Worsley R, Miller KK, Parish SJ, Santoro N. Androgens and female sexual function and dysfunction--findings from the Fourth International Consultation of Sexual Medicine. J Sex Med. 2016, 13:168-178. 10.1016\/j.jsxm.2015.12.033","journal-title":"J Sex Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline","volume":"99","author":"Wierman ME","year":"2014","unstructured":"Wierman ME, Arlt W, Basson R, et al.. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:3489-3510. 10.1210\/jc.2014-2260","journal-title":"J Clin Endocrinol Metab"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis SR","year":"2005","unstructured":"Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005, 294:91-96. 10.1001\/jama.294.1.91","journal-title":"JAMA"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-020-00294-8","article-title":"Sex differences in vascular aging in response to testosterone","volume":"11","author":"Moreau KL","year":"2020","unstructured":"Moreau KL, Babcock MC, Hildreth KL. Sex differences in vascular aging in response to testosterone. Biol Sex Differ. 2020, 11:18. 10.1186\/s13293-020-00294-8","journal-title":"Biol Sex Differ"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.1943.02840010019004","article-title":"Testosterone propionate pellet implantation in gynecic disorders","volume":"121","author":"Greenblatt RB","year":"1943","unstructured":"Greenblatt RB. Testosterone propionate pellet implantation in gynecic disorders. JAMA. 1943, 121:17-24. 10.1001\/JAMA.1943.02840010019004","journal-title":"JAMA"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(97)80988-7","article-title":"The effect of exogenous testosterone on lipid metabolism and insulin resistance in postmenopausal women","volume":"27","author":"Sands R","year":"1996","unstructured":"Sands R, Studd J, Seed M, et al.. The effect of exogenous testosterone on lipid metabolism and insulin resistance in postmenopausal women. Maturitas. 1996, 27:50. 10.1016\/S0378-5122(97)80988-7","journal-title":"Maturitas"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/17.6.497","article-title":"The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women","volume":"17","author":"Seed M","year":"2000","unstructured":"Seed M, Sands RH, McLaren M, Kirk G, Darko D. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women. Fam Pract. 2000, 17:497-507. 10.1093\/fampra\/17.6.497","journal-title":"Fam Pract"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(09)70288-9","article-title":"Efficacy of testosterone therapy delivered by pellet implant","volume":"63","author":"Glaser R","year":"2009","unstructured":"Glaser R, Wurtzbacher D, Dimitrakakis C. Efficacy of testosterone therapy delivered by pellet implant. Maturitas. 2009, 63:73-74. 10.1016\/S0378-5122(09)70288-9","journal-title":"Maturitas"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb03280.x","article-title":"Does testosterone affect the normal menstrual cycle?","volume":"24","author":"Dewis P","year":"1986","unstructured":"Dewis P, Newman M, Ratcliffe WA, Anderson DC. Does testosterone affect the normal menstrual cycle?. Clin Endocrinol (Oxf). 1986, 24:515-521. 10.1111\/j.1365-2265.1986.tb03280.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3109\/13697131003675922","article-title":"Testosterone treatment of HSDD in naturally menopausal women: the ADORE study","volume":"13","author":"Panay N","year":"2010","unstructured":"Panay N, Al-Azzawi F, Bouchard C, et al.. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010, 13:121-131. 10.3109\/13697131003675922","journal-title":"Climacteric"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040619","article-title":"Cardiovascular safety and benefits of testosterone implant therapy in postmenopausal women: where are we?","volume":"16","author":"Renke G","year":"2023","unstructured":"Renke G, Tostes F. Cardiovascular safety and benefits of testosterone implant therapy in postmenopausal women: where are we?. Pharmaceuticals (Basel). 2023, 16:619. 10.3390\/ph16040619","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.11.002","article-title":"The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women","volume":"93","author":"Clayton AH","year":"2018","unstructured":"Clayton AH, Goldstein I, Kim NN, et al.. The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc. 2018, 93:467-487. 10.1016\/j.mayocp.2017.11.002","journal-title":"Mayo Clin Proc"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.028","article-title":"Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis","volume":"107","author":"Achilli C","year":"2017","unstructured":"Achilli C, Pundir J, Ramanathan P, Sabatini L, Hamoda H, Panay N. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril. 2017, 107:475-482.e15. 10.1016\/j.fertnstert.2016.10.028","journal-title":"Fertil Steril"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren LJ","year":"2008","unstructured":"Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008, 93:19-25. 10.1210\/jc.2007-1809","journal-title":"J Clin Endocrinol Metab"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females","volume":"5","author":"Gooren LJG","year":"2008","unstructured":"Gooren LJG, Giltay EJ. Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. J Sex Med. 2008, 5:765-776. 10.1111\/j.1743-6109.2007.00646.x","journal-title":"J Sex Med"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy212","article-title":"Different menopausal hormone regimens and risk of breast cancer","volume":"29","author":"Brusselaers N","year":"2018","unstructured":"Brusselaers N, Tamimi RM, Konings P, Rosner B, Adami HO, Lagergren J. Different menopausal hormone regimens and risk of breast cancer. Ann Oncol. 2018, 29:1771-1776. 10.1093\/annonc\/mdy212","journal-title":"Ann Oncol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie F","year":"2003","unstructured":"Labrie F, Luu-The V, Labrie C, B\u00e9langer A, Simard J, Lin SX, Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev. 2003, 24:152-182. 10.1210\/er.2001-0031","journal-title":"Endocr Rev"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13028","article-title":"Does transdermal testosterone increase the risk of developing breast cancer? a systematic review","volume":"38","author":"Gera R","year":"2018","unstructured":"Gera R, Tayeh S, Chehade HE, Mokbel K. Does transdermal testosterone increase the risk of developing breast cancer? a systematic review. Anticancer Res. 2018, 38:6615-6620. 10.21873\/anticanres.13028","journal-title":"Anticancer Res"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00811-2","article-title":"Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study","volume":"14","author":"Li Z","year":"2023","unstructured":"Li Z, Wang M, Hua M, et al.. Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study. Discov Oncol. 2023, 14:198. 10.1007\/s12672-023-00811-2","journal-title":"Discov Oncol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-023-02773-6","article-title":"Systematic review on gender-affirming testosterone therapy and the risk of breast cancer: a challenge for physicians treating patients from transgender and gender-diverse populations","volume":"53","author":"Pamulapati S","year":"2024","unstructured":"Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S. Systematic review on gender-affirming testosterone therapy and the risk of breast cancer: a challenge for physicians treating patients from transgender and gender-diverse populations. Arch Sex Behav. 2024, 53:1969-1980. 10.1007\/s10508-023-02773-6","journal-title":"Arch Sex Behav"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-547","article-title":"Low salivary testosterone levels in patients with breast cancer","volume":"10","author":"Dimitrakakis C","year":"2010","unstructured":"Dimitrakakis C, Zava D, Marinopoulos S, Tsigginou A, Antsaklis A, Glaser R. Low salivary testosterone levels in patients with breast cancer. BMC Cancer. 2010, 10:547. 10.1186\/1471-2407-10-547","journal-title":"BMC Cancer"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2413","article-title":"Androgens and the breast","volume":"11","author":"Dimitrakakis C","year":"2009","unstructured":"Dimitrakakis C, Bondy C. Androgens and the breast. Breast Cancer Res. 2009, 11:212. 10.1186\/bcr2413","journal-title":"Breast Cancer Res"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01886-7","article-title":"Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy","volume":"26","author":"Taranto P","year":"2024","unstructured":"Taranto P, de Brito Sales D, Maluf FC, et al.. Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy. Breast Cancer Res. 2024, 26:133. 10.1186\/s13058-024-01886-7","journal-title":"Breast Cancer Res"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00516.x","article-title":"Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies","volume":"4","author":"Braunstein GD","year":"2007","unstructured":"Braunstein GD. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies. J Sex Med. 2007, 4:859-866. 10.1111\/j.1743-6109.2007.00516.x","journal-title":"J Sex Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901334","article-title":"Testosterone therapy in women: a review","volume":"17","author":"Bolour S","year":"2005","unstructured":"Bolour S, Braunstein G. Testosterone therapy in women: a review. Int J Impot Res. 2005, 17:399-408. 10.1038\/sj.ijir.3901334","journal-title":"Int J Impot Res"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1093\/jsxmed\/qdae032","article-title":"Testosterone therapy in females is not associated with increased cardiovascular or breast cancer risk: a claims database analysis","volume":"21","author":"Agrawal P","year":"2024","unstructured":"Agrawal P, Singh SM, Hsueh J, et al.. Testosterone therapy in females is not associated with increased cardiovascular or breast cancer risk: a claims database analysis. J Sex Med. 2024, 21:414-419. 10.1093\/jsxmed\/qdae032","journal-title":"J Sex Med"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2171","article-title":"Effects of testosterone treatment on endometrial proliferation in postmenopausal women","volume":"92","author":"Zang H","year":"2007","unstructured":"Zang H, Sahlin L, Masironi B, Eriksson E, Lind\u00e9n Hirschberg A. Effects of testosterone treatment on endometrial proliferation in postmenopausal women. J Clin Endocrinol Metab. 2007, 92:2169-2175. 10.1210\/jc.2006-2171","journal-title":"J Clin Endocrinol Metab"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01380.x","article-title":"Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals","volume":"6","author":"Perrone AM","year":"2009","unstructured":"Perrone AM, Cerpolini S, Maria Salfi NC, et al.. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. J Sex Med. 2009, 6:3193-3200. 10.1111\/j.1743-6109.2009.01380.x","journal-title":"J Sex Med"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo JC","year":"2006","unstructured":"Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:1357-1363. 10.1210\/jc.2005-2430","journal-title":"J Clin Endocrinol Metab"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo F","year":"2010","unstructured":"Iellamo F, Volterrani M, Caminiti G, et al.. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol. 2010, 56:1310-1316. 10.1016\/j.jacc.2010.03.090","journal-title":"J Am Coll Cardiol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad132","article-title":"The impact of testosterone therapy on cardiovascular risk among postmenopausal women","volume":"8","author":"Britton RC","year":"2023","unstructured":"Britton RC, Beamish NF. The impact of testosterone therapy on cardiovascular risk among postmenopausal women. J Endocr Soc. 2023, 8:bvad132. 10.1210\/jendso\/bvad132","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385662-testosterone-therapy-in-women-a-literature-review-of-clinical-indications-dosing-routes-of-administration-and-safety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:48:32Z","timestamp":1775738912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385662-testosterone-therapy-in-women-a-literature-review-of-clinical-indications-dosing-routes-of-administration-and-safety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":113,"URL":"https:\/\/doi.org\/10.7759\/cureus.106713","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}